Skip to content

Efficacy of Mindfulness-based Stress Reduction in Hemodialysis Patients with Anxiety and Depression: a randomized, double-blind, parallel-group trial

Mostafa Haghshenas, Fatemeh Assarian, Abdollah Omidi, Mohammadreza Razaghof, Habibollah Rahimi

Electronic Physician January 22, 2020 DOI: 10.19082/7370 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized clinical trial Double-blind Peer reviewed
Sample size 50
Population Hemodialysis patients from two dialysis centers in Kashan, Iran
Intervention Mindfulness-Based Stress Reduction (MBSR)
Duration Eight sessions
Topics Anxiety Depression Meditation
Keywords Renal dialysis
Key findings Depression and anxiety were reduced in the MBSR group compared with the control group.

Abstract

Background: Diseases with a chronic and debilitating nature, such as chronic kidney disease, are frequently associated with psychiatric disorders like anxiety and depression.

Objective: To assess the efficacy of mindfulness-based stress reduction (MBSR) on anxiety and depression in hemodialysis patients.

Methods: In this randomized clinical trial, fifty hemodialysis patients were selected from two dialysis centers of Kashan city in Iran in 2016. The patients had desired cognitive status based on MMSE (Mini Mental Status Examination) and clinical interview, and were randomly allocated into the intervention and control groups. The intervention group (n=25) received a Mindfulness-Based Stress Reduction (MBSR) program in addition to the health education program in eight sessions, whereas the control group (n=25) received only the health education program. To measure the anxiety and depression score before and after study, the Hospital Anxiety and Depression Scale were used. Data were analyzed by SPSS version 11.5, using Analysis of Covariance (ANCOVA), t-test, Chi-square, Mann-Whitney U, and Fisher exact test.

Results: The mean age of intervention and control groups were 46.86±11.66 and 46.26±11.71 respectively. The mean duration of illness was 2.47±1.78 and 2.62±1.32 in intervention and control groups respectively. There were no significant differences between the two groups regarding age, sex, education level and job. Depression and anxiety were reduced in the intervention group compared with the control group (p=0.0001).

Conclusions: The MBSR program may reduce anxiety and depression in hemodialysis patients.

Funding: This study was financially supported by the Deputy of Research, Kashan University of Medical Sciences, Kashan, Iran (Ref: 9436). Clinical

Trial Registration: The protocol of study was registered at the Iranian Registry of Clinical Trials (IRCT) with ID number of IRCT2015081723652N1.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics